GÖKÇE CİHAN ÜSTÜNDAĞ, NURTEN ÖZSOY, EZGİ ÖZTAŞ, NİLGÜN LÜTFİYE KARALI, Gültaze ÇAPAN

Antioxidant and cytotoxic properties of novel spirocyclic benzothiazolines

In this work, we report the synthesis, structural characterization and evaluation of in vitro antioxidant and cytotoxic properties of novel spirobenzothiazolines (1a-e, 2a-e). 5-nonsubstituted spirobenzothiazolines (1a-e) demonstrated notable inhibitory capacity on lipid peroxidation (LPO), reducing power and scavinging effects on diphenylpicryl hydrazine (DPPH˙) and 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid (ABTS˙+) radicals, that were similar to that of α-tocopherol. The most potent antioxidant was compound 1a (incorporating an ethyl group on the cyclohexane ring) with an anti-LPO activity 2-fold higher than that of α-tocopherol. Compound 1a exhibited anti-LPO and DPPH˙ scavenging activities at concentrations lower than those cytotoxic for mouse normal fibroblast (NIH/3T3) cells and was also found to be slightly more selective for cancer cells (human prostat adenocarcinoma cell/PC-3) than normal mammalian cells.

PDF

___

van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol Biol 2011; 731: 237-45.

Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal Biochem 1996; 239; 70-6.

Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, RiceEvans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26: 1231-7.

Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. Food Sci TechnolLEB 1995; 28: 25-30.

Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.

Duh PD, Tu YY, Yen GC. Antioxidant activity of water extract of Harng Jyur (Chrysanthemum morifolium Ramat). Food Sci Technol-LEB 1999; 32: 269-77.

Akkurt M, Cihan-Üstündağ G, Çapan G, Dağdemir Y, Tahir N. 4′-tert-Butyl-5-chloro-3H-spiro [1,3-benzothia zole-2,1′cyclo hexa ne]. Acta Crystallogr Sect E 2012; 68: o1542.

Akkurt M, Cihan-Üstündağ G, Çapan G, Türktekin-Çelikesir S, Tahir MN. 5-Chloro-4′-ethyl-3H-spiro [1,3-benzo thia zole2,1′-cyclo hexa ne]. Acta Crystallogr Sect E. 2012; 68(5): o1466.

Coudert P, Couquelet J, Sudre O, Bastide J. Synthesis and analgesic activity of new spiro-derivatives of benzothiazoline. J Pharm Belg1988; 43: 258-62.

Shrestha R, Sharma K, Lee YR, Wee YJ. Cerium oxide-catalyzed multicomponent condensation approach to spirooxindoles in water. Mol Divers 2016; 20: 847-58.

Dandia A, Saini D, Bhaskaran S, Saini DK. Ultrasound promoted green synthesis of spiro[pyrano[2,3-c]pyrazoles] as antioxidant agents. Med Chem Res 2014; 23: 725-34.

Youssef MM, Amin MA. Microwave assisted synthesis of some new heterocyclic spiro-derivatives with potential antimicrobial and antioxidant activity. Molecules 2010; 15: 8827-40.

Panteleon V, Marakos P, Pouli N, Mikros E, Andreadou I. Synthesis, conformational analysis and free radical scavenging activity of some new spiropyranoquinolinones. Chem Pharm Bull 2003; 51: 522-9.

Ermut G, Karalı N, Özsoy N, Can A. New spiroindolinones bearing 5-chlorobenzothiazole moiety. J Enzyme Inhib Med Chem 2014; 29: 457-68.

Karalı N, Güzel Ö, Özsoy N, Özbey S, Salman A. Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents. Eur J Med Chem 2010; 45:1068-77.

Chripkova M, Zigo F, Mojzis J. Antiproliferative effect of indole phytoalexins. Molecules 2016; 21: 1626-41.

Pilátová M, Sarisský M, Kutschy P, Mirossay A, Mezencev R, Curillová Z, Suchý M, Monde K, Mirossay L, Mojzis J. Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells. Leuk Res 2005; 29: 415-21.

Sabol M, Kutschy P, Siegfried L, Mirossay A, Suchy M, Hrbkova H, Dzurilla M, Maruskova R, Starkova J, Paulikova E. Cytotoxic effect of cruciferous phytoalexins against murine L1210 leukemia and B16 melanoma. Biologia 2000; 55: 701–7.

Mehta RG, Liu J, Constantinou A, Thomas CF, Hawthorne M, You M, Gerhäuser C, Pezzuto JM, Moon RC, Moriarty RM. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 1995; 16: 399–404.

Purkayastha RP. Progress in phytoalexin research during the past 50 years. In: Daniel P, Purkayastha RP. (Eds). Handbook of Phytoalexin Metabolism and Action. Marcel Dekker, Inc., New York, 1995, pp.1-40.

Roche SP, Porco JA. Dearomatization strategies in the synthesis of complex natural products. Angew Chem Int Ed 2011; 50: 4068-93.

Le Gal K, Ibrahim MX, Wiel C, Sayın VI, Akula MK, Karlsson C, Dalin MG, Akyurek LM, Lindahl P, Nilsson J, Bergo MO. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med 2015; 7: 308re8.

Goodman M, Bostick RM, Kucuk O, Jones DP. Clinical trials of antioxidants as cancer prevention agents: Past, present, and future. Free Radic Biol Med 2011; 51: 1068-84.

Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment. Integr Cancer Ther 2016; 15: 17-39.

Menon S, Lu C, Menon R, Schwartz J, Guan Y. Effects of antioxidants in human cancers: Differential effects on noncoding intronic RNA expression. Antioxidants 2016; 5: 1-17.

Özben T. Antioxidant supplementation on cancer risk and during cancer therapy: an update. Curr Top Med Chem 2015; 15: 170-8.

Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition 2013; 29:15-21.

Ostrovidov S, Franck P, Joseph D, Martarello L, Kirsch G, Belleville F, Nabet P, Dousset B. Screening of new antioxidant molecules using flow cytometry. J Med Chem 2000; 43:1762-9.

Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.

Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharm 2014; 92: 90-101.